JP2023545501A5 - - Google Patents
Info
- Publication number
- JP2023545501A5 JP2023545501A5 JP2023522978A JP2023522978A JP2023545501A5 JP 2023545501 A5 JP2023545501 A5 JP 2023545501A5 JP 2023522978 A JP2023522978 A JP 2023522978A JP 2023522978 A JP2023522978 A JP 2023522978A JP 2023545501 A5 JP2023545501 A5 JP 2023545501A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063093029P | 2020-10-16 | 2020-10-16 | |
| US63/093,029 | 2020-10-16 | ||
| PCT/US2021/055216 WO2022081997A1 (en) | 2020-10-16 | 2021-10-15 | Compositions and methods for treating blood disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023545501A JP2023545501A (ja) | 2023-10-30 |
| JP2023545501A5 true JP2023545501A5 (https=) | 2024-10-22 |
| JPWO2022081997A5 JPWO2022081997A5 (https=) | 2024-10-22 |
Family
ID=81208704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023522978A Pending JP2023545501A (ja) | 2020-10-16 | 2021-10-15 | 血液障害を処置するための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230391858A1 (https=) |
| EP (1) | EP4228696A4 (https=) |
| JP (1) | JP2023545501A (https=) |
| KR (1) | KR20230087572A (https=) |
| AU (1) | AU2021361067A1 (https=) |
| CA (1) | CA3195798A1 (https=) |
| MX (1) | MX2023004429A (https=) |
| WO (1) | WO2022081997A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015006507A1 (en) | 2013-07-09 | 2015-01-15 | Annexon, Inc. | Methods of treatment for alzheimer's disease and huntington's disease |
| WO2023114763A1 (en) * | 2021-12-13 | 2023-06-22 | Annexon, Inc. | Anti-complement factor c1q antibodies with single binding arms and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015006507A1 (en) * | 2013-07-09 | 2015-01-15 | Annexon, Inc. | Methods of treatment for alzheimer's disease and huntington's disease |
| HUE070383T2 (hu) * | 2014-11-05 | 2025-06-28 | Annexon Inc | Humanizált C1Q anti-komplement faktor antitestek és alkalmazásaik |
| WO2017091719A1 (en) * | 2015-11-24 | 2017-06-01 | Annexon, Inc. | Anti-complement factor c1q fab fragments and uses thereof |
| WO2021076991A1 (en) * | 2019-10-17 | 2021-04-22 | Annexon, Inc. | Compositions and methods for treating blood disorders |
-
2021
- 2021-10-15 CA CA3195798A patent/CA3195798A1/en active Pending
- 2021-10-15 US US18/032,084 patent/US20230391858A1/en active Pending
- 2021-10-15 EP EP21881186.7A patent/EP4228696A4/en active Pending
- 2021-10-15 WO PCT/US2021/055216 patent/WO2022081997A1/en not_active Ceased
- 2021-10-15 JP JP2023522978A patent/JP2023545501A/ja active Pending
- 2021-10-15 AU AU2021361067A patent/AU2021361067A1/en active Pending
- 2021-10-15 MX MX2023004429A patent/MX2023004429A/es unknown
- 2021-10-15 KR KR1020237016264A patent/KR20230087572A/ko active Pending